TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3060461

Group type: EXPERIMENTAL
Intervention: Roxithromycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erythromycin ethylsuccinate
Number of subjects: 0
Study: 31119938

Group type: EXPERIMENTAL
Intervention: Nonspherical biosynthetic bubbles
Number of subjects: 0
Study: 28566854

Group type: EXPERIMENTAL
Intervention: Hyrax RME appliance
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fan-type RME appliance
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fan-type RME
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hyrax
Number of subjects: 12
Study: 26147383

Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation (500 μg vitamin B12 and 400 μg folic acid)
Number of subjects: 2919

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2919
Study: 23341184

Group type: EXPERIMENTAL
Intervention: Tonojet disposable tonometer
Number of subjects: 293

Group type: COMPARATOR
Intervention: Goldmann tonometer
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Tonojet disposable tonometer in eyes with ocular hypertension/glaucoma
Number of subjects: 293

Group type: COMPARATOR
Intervention: Goldmann tonometer in eyes with ocular hypertension/glaucoma
Number of subjects: 293
Study: 22021297

Group type: EXPERIMENTAL
Intervention: AMIGAS intervention (4 sessions)
Number of subjects: 252

Group type: COMPARATOR
Intervention: 1-session health intervention
Number of subjects: 252
Study: 18430451

Group type: EXPERIMENTAL
Intervention: Angles in isosceles triangles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Angles in scalene triangles
Number of subjects: 0
Study: 19912283

Group type: EXPERIMENTAL
Intervention: Topical diltiazem (DTZ) ointment (2%; n = 16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo ointment (n = 17)
Number of subjects: 33
Study: 16145097

Group type: EXPERIMENTAL
Intervention: Intravaginal metronidazole
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Intravaginal clindamycin
Number of subjects: 119

Group type: COMPARATOR
Intervention: Both therapies (metronidazole and clindamycin)
Number of subjects: 119
Study: 11966862

Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 1321

Group type: EXPERIMENTAL
Intervention: Almotriptan 6.25 mg
Number of subjects: 1321

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1321
Study: 9688625

Group type: COMPARATOR
Intervention: Baseline conditions (normal nighttime sleep)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Day 1 (after sleep deprivation)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Day 2 (after sleep shift)
Number of subjects: 15
Study: 8136641

Group type: EXPERIMENTAL
Intervention: Relaxation training by audio tapes
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Live relaxation training by nurses
Number of subjects: 67

Group type: COMPARATOR
Intervention: No relaxation training (Control)
Number of subjects: 67
Study: 2909831

Group type: EXPERIMENTAL
Intervention: Aspartame (APM) at 10 mg APM/kg body weight per serving, ingested in three successive 12-oz servings at 2-hour intervals (study 1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aspartame (APM) at 30 mg APM/kg body weight as a single bolus (study 2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (beverage not sweetened) in study 1
Number of subjects: 12
Study: 60623

Group type: EXPERIMENTAL
Intervention: Fresh-frozen plasma (F.F.P) 12 ml/kg body-weight
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrates
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Factor-VII concentrate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined administration of lower dose of F.F.P. (8 ml/kg body-weight) and both concentrates (12 units/ml)
Number of subjects: 30
Study: 30594760

Group type: EXPERIMENTAL
Intervention: 10 sessions of individual CBT adjunctive to treatment as usual (TAU)
Number of subjects: 80

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 80
Study: 30541592

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 0
Study: 26920910

Group type: EXPERIMENTAL
Intervention: C. caudatus treated group (U)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 100
Study: 24553532

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) counseling
Number of subjects: 200

Group type: COMPARATOR
Intervention: No discussion (Control)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 200
Study: 22431971

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) with an amino acid beverage lacking tryptophan
Number of subjects: 40

Group type: COMPARATOR
Intervention: TRP-balanced amino acid beverage (BAL)
Number of subjects: 40
Study: 19453695

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization (TACE) with lipiodol, doxorubicin and cisplatin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Systemic doxorubicin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization (TACE)
Number of subjects: 100
Study: 17484866

Group type: EXPERIMENTAL
Intervention: Isobaric distention to unpleasant or painful sensation
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham distention
Number of subjects: 13

Group type: COMPARATOR
Intervention: No distention
Number of subjects: 13
Study: 15465636

Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) during saccadic task
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) during antisaccadic task
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) during smooth pursuit at 20 degrees/s
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) during smooth pursuit at 40 degrees/s
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Older subjects (over 60 years) compared to middle-aged subjects (41-60 years)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Head movement gain during gaze shifts
Number of subjects: 53
Study: 11430619

Group type: EXPERIMENTAL
Intervention: Foldable intraocular lens (IOL)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Rigid intraocular lens (IOL)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups (Rigid IOL and Foldable IOL)
Number of subjects: 82
Study: 9855069

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 30
Study: 7843980

Group type: EXPERIMENTAL
Intervention: Stages of change in dietary fat consumption
Number of subjects: 17121

Group type: EXPERIMENTAL
Intervention: Stages of change in dietary fiber consumption
Number of subjects: 17121

Group type: EXPERIMENTAL
Intervention: Stage of change
Number of subjects: 17121
Study: 2645561

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 50 mg (q.i.d.)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Nefopam 60 mg (q.i.d.)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 640 mg + codeine 40 mg (q.i.d.)
Number of subjects: 99
Study: 29482213

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Education (EDU)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 290
Study: 28522078

Group type: EXPERIMENTAL
Intervention: Positional therapy (PT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Oral appliance therapy (OAT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Sleep position trainer (SPT)
Number of subjects: 99
Study: 26275236

Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (c‐tDCS) of M1, S1 and DLPFC at 0.3 mA for 20 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (c‐tDCS) of S1, M1 and DLPFC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (c‐tDCS) of M1, S1 and DLPFC
Number of subjects: 0
Study: 23039931

Group type: EXPERIMENTAL
Intervention: Active rTMS treatment (n = 13)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham rTMS treatment (n = 12)
Number of subjects: 27
Study: 20363906

Group type: EXPERIMENTAL
Intervention: Outgroup critics with internal attributions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Outgroup critics with external attributions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ingroup critics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outgroup criticism with an outgroup audience
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concerns about ingroup's image
Number of subjects: 0
Study: 19241895

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GC)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Vinorelbine plus cisplatin (VC)
Number of subjects: 83
Study: 16352625

Group type: EXPERIMENTAL
Intervention: 0.9% saline + 2.5% dextrose (NS)
Number of subjects: 102

Group type: COMPARATOR
Intervention: 0.45% saline + 2.5% dextrose (N/2)
Number of subjects: 102
Study: 11800219

Group type: EXPERIMENTAL
Intervention: Intake appointments scheduled 1 day later
Number of subjects: 116

Group type: COMPARATOR
Intervention: Intake appointments scheduled 3 days later
Number of subjects: 116

Group type: COMPARATOR
Intervention: Intake appointments scheduled 7 days later
Number of subjects: 116
Study: 10909473

Group type: EXPERIMENTAL
Intervention: IDDM patients (19 patients)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: NIDDM patients (16 patients)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control groups (matched by age and gender)
Number of subjects: 35
Study: 8625129

Group type: EXPERIMENTAL
Intervention: Urinary beta-glucuronidase activity
Number of subjects: 146
Study: 2286487

Group type: EXPERIMENTAL
Intervention: Percussive vibratory massage for 4 min followed by 1 min of rest
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition with 5 min rest between series of contractions
Number of subjects: 12
Study: 7208897

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized projects
Number of subjects: 0
Study: 31759645

Group type: EXPERIMENTAL
Intervention: General public's risk perceptions from environmental exposures
Number of subjects: 338

Group type: COMPARATOR
Intervention: Expert evaluations of risk associated with environmental exposures
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Explanatory models of risk perceptions
Number of subjects: 338
Study: 28863074

Group type: EXPERIMENTAL
Intervention: CHO (22.5 g) alone
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Pro-CHO (CHO (15 g) + whey protein (10 g))
Number of subjects: 27
Study: 27246662

Group type: EXPERIMENTAL
Intervention: Transducer and needle alignment in a sagittal plane, perpendicular to the shoulders
Number of subjects: 28

Group type: COMPARATOR
Intervention: Transducer and needle alignment in a coronal plane, parallel to the shoulders
Number of subjects: 28
Study: 25680925

Group type: EXPERIMENTAL
Intervention: rhC1INH (50 IU/kg)
Number of subjects: 44
Study: 23593639

Group type: EXPERIMENTAL
Intervention: Experimental setup for fixing microtensile sticks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Flat Ciucchi's jig
Number of subjects: 12
Study: 20939474

Group type: EXPERIMENTAL
Intervention: High-flexion prostheses
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard cruciate-stabling prostheses
Number of subjects: 144
Study: 18719788

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine group (n=13): infusion of 1 microg/kg over 10 minutes and maintenance dose of 0.5 microg/kg/h as an adjuvant to inhaled isoflurane anesthesia
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (n=13): normal saline infusion at a similar rate and volume of the dexmedetomidine infusion
Number of subjects: 26
Study: 17027362

Group type: EXPERIMENTAL
Intervention: 600 mg mifepristone (group I)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 800 microg misoprostol (group II)
Number of subjects: 115
Study: 14623704

Group type: EXPERIMENTAL
Intervention: 15% azelaic acid gel
Number of subjects: 251

Group type: COMPARATOR
Intervention: 0.75% metronidazole gel
Number of subjects: 251
Study: 11078311

Group type: EXPERIMENTAL
Intervention: High-fat meal (900 calories, 50 g of fat)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low-fat meal (900 calories, 4 g of fat)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-fat meal
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low-fat meal
Number of subjects: 15
Study: 9378463

Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 16
Study: 8271174

Group type: EXPERIMENTAL
Intervention: PMMA IOLs (AMO PC58)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Silicone IOLs (AMO SI19, Adatomed 90D)
Number of subjects: 43
Study: 3623739

Group type: EXPERIMENTAL
Intervention: Euphyllin retard
Number of subjects: 18

Group type: COMPARATOR
Intervention: PulmiDur
Number of subjects: 18
Study: 30420421

Group type: EXPERIMENTAL
Intervention: ACE inhibitor monotherapy
Number of subjects: 1243

Group type: EXPERIMENTAL
Intervention: ARB monotherapy
Number of subjects: 1243

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 1243

Group type: COMPARATOR
Intervention: ACE inhibitor
Number of subjects: 1243

Group type: COMPARATOR
Intervention: ARB
Number of subjects: 1243

Group type: COMPARATOR
Intervention: ACE inhibitor or ARB monotherapy or combination therapy
Number of subjects: 1243
Study: 27593617

Group type: EXPERIMENTAL
Intervention: Beetroot juice (140 ml daily, containing approximately 10 mmol of nitrate)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (blackcurrant cordial with negligible nitrate content)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Beetroot juice
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (blackcurrant cordial)
Number of subjects: 40
Study: 25014057

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Losartan (100 mg/day)
Number of subjects: 42
Study: 22193531

Group type: EXPERIMENTAL
Intervention: Fluoxetine (10 mg/day to 80 mg/day over 12 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 21105275

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0
Study: 18197096

Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg/dose
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 16180596

Group type: EXPERIMENTAL
Intervention: MOVE curriculum (experimental group, n=32)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Regular programme (control group, n=12)
Number of subjects: 44
Study: 12204020

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Mammography screening in women younger than 50 years
Number of subjects: 154

Group type: COMPARATOR
Intervention: Clinical breast examination and breast self-examination
Number of subjects: 154
Study: 9836061

Group type: EXPERIMENTAL
Intervention: PTSD subjects (16)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Combat controls (9)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Noncombat subjects (12)
Number of subjects: 37
Study: 8137520

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg, subcutaneous injection)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2573377

Group type: EXPERIMENTAL
Intervention: 5 mg tertatolol (T)
Number of subjects: 61

Group type: COMPARATOR
Intervention: 100 mg atenolol (A)
Number of subjects: 61
Study: 1053694

Group type: EXPERIMENTAL
Intervention: Combined modality therapy (chemotherapy and irradiation)
Number of subjects: 0
Study: 6928417

Group type: EXPERIMENTAL
Intervention: Alkaline sodium fluoride dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral sodium fluoride dentifrice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31481475

Group type: EXPERIMENTAL
Intervention: End-of-life care integrated into clinical care when a life-limiting prognosis was articulated.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Informal care plans developed gradually without discussing with patients.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: GPs' provision of end-of-life care influenced by patient traits and GP characteristics.
Number of subjects: 15
Study: 28693427

Group type: EXPERIMENTAL
Intervention: Remote pharmacist-led intervention
Number of subjects: 461

Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Both intervention and control sites
Number of subjects: 461
Study: 25259559

Group type: EXPERIMENTAL
Intervention: Upper limb (UL) training
Number of subjects: 46
Study: 24907946

Group type: EXPERIMENTAL
Intervention: Nasogastric decompression postoperatively
Number of subjects: 115

Group type: COMPARATOR
Intervention: No nasogastric decompression postoperatively
Number of subjects: 115
Study: 22428494

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg of ketamine (Group K1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg of ketamine (Group K2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal saline (Group N)
Number of subjects: 45
Study: 19817264

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii + metronidazole
Number of subjects: 85

Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 85
Study: 17143189

Group type: EXPERIMENTAL
Intervention: mibefradil 100 mg daily
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: amlodipine 10 mg daily
Number of subjects: 14
Study: 15334195

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL) 2 mg/day, po with CsA (8-10 mg/kg/day, po) and prednisone (0.5 mg/day, po)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Azathioprine (AZA) 2 mg/kg/day, po with CsA (8-10 mg/kg/day, po) and prednisone (0.5 mg/day, po)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 90
Study: 12488133

Group type: EXPERIMENTAL
Intervention: Vitamin E-bonded hemodialyzer for 6 months
Number of subjects: 41

Group type: COMPARATOR
Intervention: Regular hemodialyzer after switching from vitamin E-bonded hemodialyzer
Number of subjects: 41
Study: 9830249

Group type: EXPERIMENTAL
Intervention: Psychopathology (externalizing symptoms, internalizing symptoms)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Socialization factors (peer influences, parental support, parental approval of use)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Parental support and control
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Internalizing pathology
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Externalizing symptoms, parental alcoholism, peer influences, parental support
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Externalizing symptoms, internalizing symptoms, peer influences, parental approval of use
Number of subjects: 216
Study: 7926110

Group type: COMPARATOR
Intervention: Transvaginal ultrasonographic examination during stimulated cycles, controlled endometrial cycles, and natural cycles.
Number of subjects: 405
Study: 2506754

Group type: EXPERIMENTAL
Intervention: Rilmenidine 1 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Rilmenidine 2 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Rilmenidine 1 mg and 2 mg
Number of subjects: 6
Study: 1098875

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg on the first day followed by 100 mg daily for a total of 7 days)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ampicillin (250 mg 4 times daily for 7 days)
Number of subjects: 44
Study: 31062295

Group type: EXPERIMENTAL
Intervention: At-home, long-duration transcranial motor cortex stimulation (H-tDCS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation (20% of sessions)
Number of subjects: 12
Study: 28767566

Group type: EXPERIMENTAL
Intervention: Shi-style cervical manipulations (SCM)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Mechanical cervical traction (MCT)
Number of subjects: 359
Study: 26346874

Group type: EXPERIMENTAL
Intervention: Berg Balance Scale (BBS)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 30 s chair stand test (CST)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 6 m walking test
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Berg Balance Scale (BBS) internal consistency
Number of subjects: 33
Study: 23374010

Group type: EXPERIMENTAL
Intervention: Weight gain rate between 0 and 3 months
Number of subjects: 12171

Group type: EXPERIMENTAL
Intervention: Current weight and height
Number of subjects: 12171

Group type: EXPERIMENTAL
Intervention: Weight gain variables (except birth weight)
Number of subjects: 12171
Study: 20093969

Group type: COMPARATOR
Intervention: DJ45-H (hurdle depth jump)
Number of subjects: 14

Group type: COMPARATOR
Intervention: DJ45-T (target depth jump)
Number of subjects: 14
Study: 19425819

Group type: EXPERIMENTAL
Intervention: Whole-body vibration exercise (static and dynamic tasks) twice a week for six weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (same protocol without vibratory stimulus)
Number of subjects: 24
Study: 17722826

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment at acute stage (1-10 days) at points Dicang (ST 4), Jiache (ST 6), Yangbai (GB 14), with less than 4 points selected on the face and shallow puncture, followed by electroacupuncture after 10 days.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group treated with the same methods as the treatment group but without acupuncture at the acute stage.
Number of subjects: 52
Study: 15022372

Group type: EXPERIMENTAL
Intervention: School-based preventive intervention
Number of subjects: 2678
Study: 12486439

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 11477855

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Acupuncture (AP)
Number of subjects: 46
Study: 7855937

Group type: EXPERIMENTAL
Intervention: Transrectal ultrasound (TRUS)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional digital rectal examination (DRE)
Number of subjects: 64